By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors DAHLIN, Hans; HOJDMO, Jorgen, filed on January 26, 2016, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a compa
By a News Reporter-Staff News Editor at Nanotechnology Weekly Investigators discuss new findings in Drugs and Therapies- Drug Delivery Systems. Funders for this research include Graduate Technological Innovation Project of Beijing Institute of Technology, Shanxi Province Key Laboratory of Higee-Oriented Chemical Engineering.
By a News Reporter-Staff News Editor at Clinical Trials Week A commonly-prescribed multiple sclerosis infusion medication linked to a rare but serious side effect is safer to use when dosing intervals are extended, according to a new study led by MS specialists NYU Langone Health. The authors presented their findings February 2 at the Americas Co
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors SU, Zhengxing; YANG, Likai; ZHAO, Dong; ZHOU, Jing; SHAN, Fengying; WANG, Lichun; WANG, Jingyi, filed on March 28, 2016, was made available online on February 8, 2
Patent Application Titled "Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same" Published Online. By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors DUDLEY, Robert E.; CONSTANTINI
By a News Reporter-Staff News Editor at Pharma Business Week A patent by the inventors Liao, Shouzhu; Fan, Weijie; Wang, Zhongqing, filed on October 15, 2014, was published online on February 6, 2018, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 9884859 is assigned to Sunshine Lake Pha
By a News Reporter-Staff News Editor at Nanotechnology Weekly Research findings on Drugs and Therapies- Drug Delivery Systems are discussed in a new report. According to news originating from Guangdong, People's Republic of China, by VerticalNews correspondents, research stated, "The round window membrane functions as the primary biological barri
By a News Reporter-Staff News Editor at Nanotechnology Weekly Investigators discuss new findings in Drugs and Therapies- Drug Delivery Systems. According to news reporting out of Catanzaro, Italy, by VerticalNews editors, research stated, "The use of biopolymers is increasing in drug delivery, thanks to the peculiar properties of these compounds
Global Pharmaceutical Excipients Market Analysis with Top Companies as recent as 2017 and forecasts up to 2024 that helps you track the unprecedented growth seen in Medical Device Industry giving you an edge to not just compete but to outmatch the competition. The Report provides key statistics on the market status of Global Pharmaceutical Excipien
By a News Reporter-Staff News Editor at Pharma Business Week Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration has approved Biktarvy , a once-daily single tablet regimen for the treatment of HIV-1 infection. Biktarvy has a Boxed Warning in its product label regarding the risk of post treatment acute exacerbation of hepa
Syringe injectable 3- component 150 ml, jane, needle, surgical, curved, needle disposable injection 21 g, needle injection disposable sterile, infusion system with y branching for iv infusions of infusion solutions 24 g Major organization: ST. PETERSBURG STATE BUDGET ESTABLISHMENT OF HEALTH CARE "CITY POLYCLINIC 104" Address: 194354, St. Petersburg
The US Food and Drug Administration has approved Antares Pharma Incs supplemental new drug application for the Makena auto-injector drug device. Todays announcement represents the first FDA approval of a drug-device combination product utilizing our QuickShot auto injector, said Robert Apple, the president and chief executive officer of Antares.
AB569 is made of ethylenediaminetetraacetic acid and sodium nitrite, two compounds approved by the U.S. Food and Drug Administration for human use. Arch Biopartners is now recruiting participants after delivering AB569 inhalation drug kits at the Cincinnati Veterans Affairs Medical Center, where the research will be conducted. is an important first
Albany, NY 02/17/2018 Drug delivery system are advanced engineered technologies used for the controlled release and targeted delivery of the therapeutic agents. Administering the drug locally rather than systemically would reduce the adverse effects while maximizing the treatment effects. Drug delivery systems has been changing drastically si
AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US Food and Drug Administration has approved IMFINZI for the treatment of patients with unresectable Stage III non-small cell lung cancer whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy.
A 13 F filing from George Soros also showed an increased stake in the company. Long Blockchain Corp shares rose 22.22 percent to close at $3.63. Antares Pharma, Inc. jumped 18.69 percent to close at $2.35 after the company announced the FDA approval of partner's product utilizing QuickShot Auto Injector. 500. com Limited climbed 18.02 percent to cl
WALTHAM- AMAG Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved the Makena subcutaneous auto-injector drug-device combination product as a ready-to-administer treatment to reduce the risk of preterm birth in women pregnant with one baby and who spontaneously delivered one preterm baby in the past.
Antares Pharma, Inc. today announced the successful regulatory outcome of the Makena subcutaneous auto injector collaboration with AMAG Pharmaceuticals. This first pass approval was made possible through an excellent working collaboration with our device team and the development group at AMAG, ` said Robert F. Apple, President and Chief Executive..
North America has dominated the novel drug delivery systems in the cancer therapy market in recent years whilst more and more R&D and capital enters the industry seeking the newest and most advanced therapies. The introduction of leading edge immunotherapies coupled with increasing demand for accurate diagnostic technologies are likely to trigger..
This determination will allow FDA to approve abbreviated new drug applications for benazepril hydrochloride; hydrochlorothiazide oral tablets, 5 mg and 6.25 mg, if all other legal and regulatory requirements are met. The 1984 amendments include what is now section 505 of the Federal Food, Drug, and Cosmetic Act, which requires FDA to publish a list
By a News Reporter-Staff News Editor at Health& Medicine Week Elute, Inc., an emerging leader in developing a new class of polymer-controlled drug delivery devices designed to prevent and treat orthopedic and other surgical bone infections, announced that the Company has received a notice of allowance from the United States Patent& Trademark Offi
JERUSALEM- The following are some of today's top gainers in the pharma/biotech sector. News: The FDA approved the Company's subcutaneous auto-injector form of Makena, designed as a ready-to-administer treatment, to reduce the risk of preterm birth in women who are pregnant with one baby and who spontaneously delivered one preterm baby in the past.
According to news reporting out of Lanzhou, People's Republic of China, by NewsRx editors, research stated, "Dendrimer with hyperbranched structure and multivalent surface is regarded as one of the most promising candidates close to the ideal drug delivery systems, but the clinical translation and scale-up production of dendrimer has been hampered.
Findings from University of Lorraine Update Understanding of Drug Delivery Systems. According to news reporting out of Vandoeuvre les Nancy, France, by NewsRx editors, research stated, "During the past decades, lipid nanocarriers are gaining momentum with their multiple advantages for the management of skin diseases. Our news journalists obtained a
HTF Market Intelligence released a new research report of 117 pages on title 'Global Advanced Drug Delivery Systems Market Research Report 2017' with detailed analysis, forecast and strategies.
In this report, the global...